Susan Hubbard
Pediatrics · Dallas, TXNPI 1033179031
Payments from drug & device makers
What this record shows
26 manufacturers reported payments, led by GSK at 47.4% of the total. Reporting peaked in 2022 at $2,361 and has fallen 76.1% since, to $563 in 2025. Among pediatrics clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 137 payments — averaging $34.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$2K
- Tris Pharma Inc$591
- Corium, LLC$334
- Pfizer$281
- Sanofi Pasteur Inc.$213
- Cranial Technologies, Inc$195
- plus $886 from 20 others
What the payments were for
- Speaking & faculty fees$1,95041%
- Food & beverage$2,80159%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 12 | $2,251 |
| Tris Pharma Inc | 34 | $591 |
| Corium, LLC | 14 | $334 |
| Pfizer | 13 | $281 |
| Sanofi Pasteur Inc. | 11 | $213 |
| Cranial Technologies, Inc | 11 | $195 |
| Ironshore Pharmaceuticals Inc. | 7 | $135 |
| Neos Therapeutics, LP | 7 | $130 |
| AbbVie | 1 | $125 |
| Kaleo, Inc. | 5 | $77 |
| Merck | 3 | $54 |
| Alk-abello, Inc | 2 | $51 |
| AstraZeneca | 2 | $42 |
| Genentech USA, Inc. | 2 | $39 |
| Mission Pharmacal Company | 1 | $25 |
| Cipher Pharmaceuticals US LLC | 1 | $25 |
| Arbor Pharmaceuticals, Inc. | 2 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Seqirus USA Inc | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $21 |
| Phadia US Inc. | 1 | $19 |
| LNHC, Inc | 1 | $18 |
| Verrica Pharmaceuticals Inc. | 1 | $17 |
| Aytu Biopharma, Inc. | 1 | $15 |
| Adlon Therapeutics L.p. | 1 | $14 |
| Supernus Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,751 in reported general payments places this provider in the 95th percentile of 5,361 pediatrics providers in Texas.
Other pediatrics in Dallas
- Angela ScheuerleDallas$118K
- Ralph DeberardinisDallas$56K
- Anna SuessmanDallas$26K
- Marcial Oquendo RinconDallas$21K
- Albert KaramDallas$19K
- Pedro PiedraHouston$729K
- Jason RiehsFrisco$216K
- Ivonne Sahagun-CarreonNew Braunfels$168K
- Dianna BurnsSan Antonio$100K
- Jason TerkKeller$93K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.